surmount-4 tirzepatide withdrawal weight regain Does cause significant regain? Real-world studies of GLP-1 discontinuation

When one pathway potentially adapts, the others maintain effectiveness

DOI: 10.1111/dom.14725 Wang L, Wang W, Kaelber DC, et al

Managing Side Effects by Adjusting Injection Timing Tirzepatide commonly causes mild nausea, especially in the first 2-4 hours after injection when the medication's effect on your stomach-slowing signals peaks

The article assigns the GLP-1 receptor appetite suppression, glucose control, and delayed gastric emptying, and assigns the GIP receptor insulin secretion, energy metabolism, and glucose-dependent action

Each option has its place in treatment plans, but they differ in manufacturing process, testing requirements, and overall reliability